Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center Experience

The objective of this study was to report our experience with U-VATS resection and to evaluate our surgical outcomes with an analysis of postoperative complications. The investigators also estimate the prognostic factors that influence the morbidity and the conversion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Aspergillosis Aspergillosis Bacterial Infections and Mycoses Infections Lung Diseases Lung Diseases, Fungal Mycoses Respiratory Tract Diseases Surgery-Complications Thoracic Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hassan II University

Casablanca, 20000, Morocco

About this study

Evaluation of prognostic factors Tuberculosis Hemoptysis Type of aspergilloma presence of complete adherence Procedure

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Treatment using uniportal VATS

Exclusion criteria

Resection using thoracotomy

Treatment and study plan

Uniportal VATS approach

Procedure

Uniportal VATS resection for simple pulmonary aspergilloma

VATS approach

Procedure

VATS resection for complex pulmonary aspergilloma

Primary outcomes

postoperative complications

Time frame: 30 days

evaluate the complication at 30 days

Sponsors and collaborators

Lead sponsor

Hassan II University

Other

Registry information

Important dates

Study start: 2017
Primary completion: 2020
Study completion: 2020
First posted: Aug 21, 2024
Registry last updated: Aug 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed